CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 
 

MRNA's Free Cash Flow Growth by Quarter and Year

Moderna Inc 's Free Cash Flow results by quarter and year




MRNA Free Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 1,264.29 -2.54 -2.60
III Quarter September - 892.75 -2.66 -7.01
II Quarter June 4,063.00 -23.88 0.32 -3.80
I Quarter March 2,971.00 -106.19 -2.09 -0.06
FY   7,034.00 2,026.97 -6.97 -13.47



MRNA Free Cash Flow second quarter 2021 Y/Y Growth Comment
Moderna Inc in the second quarter achieved Free Cash Flow of $ 4,063.00 millions compare to free cash outflow recorded in same quarter a year ago.

Among companies who have reported second quarter results in the Biotechnology & Pharmaceuticals industry only one Company has achieved higher year on year Free Cash Flow results in the second quarter. While Moderna Inc ' s Free Cash Flow no change of % ranks overall at the positon no. 103 in the second quarter.




MRNA Free Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Moderna Inc 's second quarter 2021 Free Cash Flow $ 4,063.00 millions MRNA's Income Statement
Moderna Inc 's second quarter 2020 Free Cash Flow $ -23.88 millions Quarterly MRNA's Income Statement
New: More MRNA's historic Free Cash Flow Growth >>


MRNA Free Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 41.62 % - -
III Quarter September - - - -
II Quarter June 36.76 % - - -
I Quarter March 134.99 % - - -
FY (Year on Year)   - - - -




Free Cash Flow second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #2
Healthcare Sector #7
Overall #103

Free Cash Flow Y/Y Growth Statistics
High Average Low
175.53 % 134.21 % 78.81 %
(Dec 31 2020)   (Jun 30 2021)
Free Cash Flow second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #2
Healthcare Sector #7
Overall #103
Free Cash Flow Y/Y Growth Statistics
High Average Low
175.53 % 134.21 % 78.81 %
(Dec 31 2020)   (Jun 30 2021)

Free Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Moderna Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
17300 % 3509.11 % 32.18 %
(Sep 30 2013)  


MRNA's II. Quarter Q/Q Free Cash Flow Comment
Moderna Inc achieved in the II. Quarter 2021 below company average Free Cash Flow jump of 36.76% quarter on quarter, to $ 4,063.00 millions.

II. Quarter 2021 results were a mixed bag, albeit beneath the ordinary, yet it demonstrates real improvement relative to the % in the same quarter a year ago Aurélaine Fernandes, Healthcare sector researcher located in Lisbon said.

Within Biotechnology & Pharmaceuticals industry 5 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Moderna Inc 's Free Cash Flow growth quarter on quarter, overall rank is 808.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #6
Healthcare Sector #75
Overall #808
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #6
Healthcare Sector #75
Overall #808
Free Cash Flow Q/Q Growth Statistics
High Average Low
17300 % 3509.11 % 32.18 %
(Sep 30 2013)  


MRNA's II. Quarter Q/Q Free Cash Flow Comment
Moderna Inc achieved in the II. Quarter 2021 below company average Free Cash Flow jump of 36.76% quarter on quarter, to $ 4,063.00 millions.

Even if the II. Quarter 2021 MRNA's Free Cash Flow sequential growth was lower than the ordinary , this was yet encouraging story, as the current expension, transcends the % Free Cash Flow growth in the II. Quarter a year ago

Within Biotechnology & Pharmaceuticals industry 5 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Moderna Inc 's Free Cash Flow growth quarter on quarter, overall rank is 808.


Moderna Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
Cumulative Free Cash Flow 12 Months Ending $ 9,298.63 $ 5,200.39 $ 2,094.42 $ 760.14 $ -135.27
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) 78.81 % 148.3 % 175.53 % - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 103 # 76 # 1070 # 214 # 0




Cumulative Free Cash Flow growth Comment
In the Jun 30 2021 period, Moderna Inc had cumulative twelve months Free Cash Flow of $ 9,299 millions compare to free cash outflow of $ -135 millions a year ago.

Moderna Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
175.53 %
134.21 %
78.81 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 7
S&P 500 # 103
Cumulative Free Cash Flow growth Comment
In the Jun 30 2021 period, Moderna Inc had cumulative twelve months Free Cash Flow of $ 9,299 millions compare to free cash outflow of $ -135 millions a year ago.

Moderna Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
175.53 %
134.21 %
78.81 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 7
S&P 500 # 103




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
MRNA's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for MRNA's Competitors
Free Cash Flow Growth for Moderna Inc 's Suppliers
Free Cash Flow Growth for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Dividend Payout Ratio
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons



Companies with similar Free Cash Flow jump for the quarter ending Jun 30 2021 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Jun 30 2021
Apollo Medical Holdings Inc -2.44%$ -2.442 millions
West Pharmaceutical Services Inc -2.50%$ -2.498 millions
Cumberland Pharmaceuticals Inc -4.13%$ -4.131 millions
Mustang Bio inc -5.00%$ -5.004 millions
Elanco Animal Health Inc-6.47%$ -6.466 millions
Merit Medical Systems Inc-7.09%$ -7.089 millions
Prestige Consumer Healthcare Inc -7.78%$ -7.783 millions
Semler Scientific inc -7.86%$ -7.863 millions
Fonar Corporation-8.08%$ -8.079 millions
United Therapeutics Corporation-9.63%$ -9.634 millions
Gilead Sciences Inc -9.74%$ -9.743 millions
Horizon Therapeutics Public Limited Company-10.24%$ -10.240 millions
Lifevantage Corp-10.43%$ -10.429 millions
Capital Senior Living Corporation-13.08%$ -13.084 millions
Neurocrine Biosciences Inc -13.20%$ -13.204 millions
Ligand Pharmaceuticals Incorporated-16.43%$ -16.426 millions
Corcept Therapeutics Inc-16.63%$ -16.634 millions
Hill rom Holdings Inc -16.70%$ -16.698 millions
Teva Pharmaceutical Industries Ltd-20.15%$ -20.147 millions
Vanda Pharmaceuticals Inc -20.78%$ -20.782 millions
Phibro Animal Health Corp-20.82%$ -20.815 millions
Novocure Limited-22.18%$ -22.181 millions
Catalent Inc -22.24%$ -22.235 millions
Immucell Corp-24.59%$ -24.595 millions
Steris Plc-27.36%$ -27.360 millions
Regional Health Properties Inc -27.45%$ -27.451 millions
Bristol Myers Squibb Co-28.32%$ -28.320 millions
Eli Lilly And Company-28.85%$ -28.849 millions
Insulet Corporation-30.68%$ -30.682 millions
Resmed Inc -31.41%$ -31.411 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ENFA's Profile

Stock Price

ENFA's Financials

Business Description

Fundamentals

Charts & Quotes

ENFA's News

Suppliers

ENFA's Competitors

Customers & Markets

Economic Indicators

ENFA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071